OncoSil Medical Ltd (AU:OSL) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
OncoSil Medical Limited is set to host an investor webinar to highlight recent milestones and strategic plans in commercializing its innovative cancer treatment device for pancreatic cancer. The company’s CEO, Nigel Lange, will discuss key achievements, including significant regulatory approvals, which position the OncoSil™ device as a leading treatment option in several global markets. Investors can gain insights into the company’s growth strategy and its potential impact on the MedTech industry.
For further insights into AU:OSL stock, check out TipRanks’ Stock Analysis page.